TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11493210

Group type: EXPERIMENTAL
Intervention: Postoperative gastric aspiration with an orogastric tube
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no gastric aspiration)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Postoperative gastric aspiration
Number of subjects: 74
Study: 9566644

Group type: EXPERIMENTAL
Intervention: T4 or T3 treatment for six months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 24
Study: 7827931

Group type: EXPERIMENTAL
Intervention: Ligation of the trunks of the inferior thyroid arteries
Number of subjects: 100

Group type: COMPARATOR
Intervention: Suture-ligation of the branches of the inferior thyroid arteries at the thyroid capsule
Number of subjects: 100
Study: 2457767

Group type: EXPERIMENTAL
Intervention: alpha-human atrial natriuretic peptide (alpha-hANP) infusion for 30 min
Number of subjects: 11
Study: 31276190

Group type: EXPERIMENTAL
Intervention: Methadone (0.2 mg/kg)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Morphine (0.2 mg/kg)
Number of subjects: 250
Study: 28419890

Group type: EXPERIMENTAL
Intervention: Enhanced Navigation (N+)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Navigation as Usual (NAU)
Number of subjects: 614
Study: 25645373

Group type: EXPERIMENTAL
Intervention: Gamma ventral capsulotomy (GVC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 16
Study: 24579274

Group type: EXPERIMENTAL
Intervention: Nanofilled-resin composite with glass-fiber layering (FRC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nanofilled-resin composite without glass-fiber layering (RC)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both FRC and RC
Number of subjects: 47
Study: 21475254

Group type: EXPERIMENTAL
Intervention: Stage-based motivational protocol for smoking cessation advice and support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education on smoking and oral health, vocational training on motivational interviewing, structured advice protocols
Number of subjects: 0
Study: 18341680

Group type: EXPERIMENTAL
Intervention: Performance-enhancing dietary supplement (DS) with 21 mg synephrine and 304 mg caffeine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 10
Study: 17947933

Group type: EXPERIMENTAL
Intervention: 250 mg/kg fructose-1,6-diphosphate (FDP)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 2.5 mM (1.4 g/L) fructose-1,6-diphosphate (FDP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5% dextrose (control)
Number of subjects: 38
Study: 14735348

Group type: EXPERIMENTAL
Intervention: Self-expanding metallic stent placement
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stoma creation
Number of subjects: 30
Study: 11292009

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (30 mg/70 kg) at infusion rates of 2, 15, and 60 seconds
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous hydromorphone (3 mg/70 kg) at infusion rates of 2, 15, and 60 seconds
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo at infusion rates of 2, 15, and 60 seconds
Number of subjects: 12
Study: 9313398

Group type: EXPERIMENTAL
Intervention: Social support intervention
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Combined social support and education intervention
Number of subjects: 363

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 363
Study: 8198308

Group type: EXPERIMENTAL
Intervention: 120 mg pseudoephedrine
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 3654236

Group type: EXPERIMENTAL
Intervention: Living with Asthma (LWA) program
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Open Airways (OA) program
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (non-participants)
Number of subjects: 400
Study: 30464449

Group type: EXPERIMENTAL
Intervention: ICS/LABA
Number of subjects: 0

Group type: COMPARATOR
Intervention: LABA alone
Number of subjects: 0
Study: 28481890

Group type: EXPERIMENTAL
Intervention: Soil-transmitted helminth infection
Number of subjects: 835

Group type: COMPARATOR
Intervention: No soil-transmitted helminth infection
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Low shuttle run performance
Number of subjects: 835
Study: 26092649

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT, 2×/wk)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Jump Training (JUMP, 3×/wk)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both RT and JUMP
Number of subjects: 38
Study: 23561068

Group type: EXPERIMENTAL
Intervention: Moderate pressure massage therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Light pressure massage therapy
Number of subjects: 42
Study: 21937367

Group type: COMPARATOR
Intervention: Standard triple treatment plus probiotic (lansoprazole, clarithromycin, amoxicillin, saccharomyces boulardii)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Levofloxacin-based therapy (esomeprazole, levofloxacin, amoxicillin for 14 days)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Levofloxacin-based triple therapy (esomeprazole and amoxicillin for 5 days, followed by esomeprazole, levofloxacin, and metronidazole for 7 days)
Number of subjects: 285
Study: 18677055

Group type: EXPERIMENTAL
Intervention: Exercise intervention for osteoporosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific protocols of exercises
Number of subjects: 0
Study: 16850448

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal suction (NPS) specimens
Number of subjects: 47

Group type: COMPARATOR
Intervention: Throat swabs
Number of subjects: 47
Study: 12701116

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) at a dose of 2,400 mg per day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 21
Study: 10939036

Group type: EXPERIMENTAL
Intervention: Theodrip (theophylline) 4.8 mg/kg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Theodrip (theophylline)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Aminophylline
Number of subjects: 9
Study: 8627041

Group type: EXPERIMENTAL
Intervention: Combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Measles-mumps-rubella and varicella vaccines at separate injection sites
Number of subjects: 0
Study: 1357306

Group type: EXPERIMENTAL
Intervention: Case finding and surveillance intervention by a specially appointed nurse after a postal questionnaire.
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control group with no questionnaires and no contact with the nurse.
Number of subjects: 369
Study: 2415097

Group type: EXPERIMENTAL
Intervention: Amino-oxyacetic acid (50 or 75 mg, four times a day orally for one week)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amino-oxyacetic acid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30958514

Group type: EXPERIMENTAL
Intervention: Mindfulness yoga
Number of subjects: 187

Group type: COMPARATOR
Intervention: Stretching and Resistance Training Exercises (SRTE)
Number of subjects: 187
Study: 30027921

Group type: EXPERIMENTAL
Intervention: Rotary technique
Number of subjects: 95

Group type: COMPARATOR
Intervention: Manual step-back technique
Number of subjects: 95
Study: 27935977

Group type: EXPERIMENTAL
Intervention: Community-based sodium reduction program with reduced-sodium, added-potassium salt substitute and health education program
Number of subjects: 1903

Group type: EXPERIMENTAL
Intervention: Community-based sodium reduction program
Number of subjects: 1903

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1903
Study: 25440382

Group type: COMPARATOR
Intervention: Acupressure wristbands
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham intervention (placebo)
Number of subjects: 26
Study: 22606978

Group type: EXPERIMENTAL
Intervention: Lactulose (Gp‐L)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No lactulose (Gp‐NL)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CFF (Critical Flicker Frequency)
Number of subjects: 120
Study: 20091824

Group type: EXPERIMENTAL
Intervention: QuBE score
Number of subjects: 284
Study: 17980550

Group type: EXPERIMENTAL
Intervention: Amitriptyline (10mg/day to start, dose elevation of 10mg/week up to 50mg/day if tolerated for eight weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 44
Study: 16135924

Group type: EXPERIMENTAL
Intervention: Oxandrolone
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 11809988

Group type: EXPERIMENTAL
Intervention: Educational intervention including a pre-school asthma booklet, a written guided self-management plan, and two 20-minute structured educational sessions with a specialist respiratory nurse.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Educational intervention.
Number of subjects: 200
Study: 10523008

Group type: EXPERIMENTAL
Intervention: 500 mg TU
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 1000 mg TU
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 500 mg TU and 1000 mg TU
Number of subjects: 32
Study: 7491882

Group type: EXPERIMENTAL
Intervention: 100 g honey
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 50 g honey
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glucose-fructose mixture (35 g each)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 20 g lactulose
Number of subjects: 20
Study: 1773906

Group type: EXPERIMENTAL
Intervention: 0.3 micrograms/kg prostaglandin E1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.6 micrograms/kg prostaglandin E1
Number of subjects: 30

Group type: COMPARATOR
Intervention: saline (group A)
Number of subjects: 30
Study: 6176313

Group type: COMPARATOR
Intervention: Chemotherapy alone (5‐FU and methyl‐CCNU)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined modality therapy (external radiotherapy of 5000 rad combined with chemotherapy)
Number of subjects: 90
Study: 30304958

Group type: EXPERIMENTAL
Intervention: PNF stretching combined with a structured exercise programme (two days per week for six weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Static stretching combined with a structured exercise programme (two days per week for six weeks)
Number of subjects: 40
Study: 29772642

Group type: EXPERIMENTAL
Intervention: Potassium bicarbonate (KHCO₃) 90 mmol∙day‐1
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16
Study: 26934216

Group type: EXPERIMENTAL
Intervention: Printed pregnancy record booklet
Number of subjects: 56
Study: 24565386

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ondansetrone 4 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal saline 5 mL
Number of subjects: 75
Study: 21533880

Group type: EXPERIMENTAL
Intervention: Gore Seamguard (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Continuous suture (group B)
Number of subjects: 90
Study: 21162796

Group type: EXPERIMENTAL
Intervention: 7.5% icodextrin (ICO)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Glucose (GLU)
Number of subjects: 54
Study: 17975182

Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 14996521

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 6
Study: 12148861

Group type: EXPERIMENTAL
Intervention: Interactive computer displays with scene magnification initially set 5% higher than VOR gain, 10 sessions of 30 minutes twice daily for 5 days
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal, x 1.0 magnification for each interaction session
Number of subjects: 9
Study: 10434216

Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg (C2)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Clonidine 0.4 mg (C4)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Esmolol (E) 300 micrograms.kg‐1 followed by a continuous infusion of 160 micrograms.kg‐1.min‐1
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 61
Study: 7822519

Group type: EXPERIMENTAL
Intervention: Calcipotriene ointment 0.005%
Number of subjects: 277

Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 277
Study: 1709511

Group type: EXPERIMENTAL
Intervention: Pantogar
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verum‐2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 597688

Group type: COMPARATOR
Intervention: Cohesive group discussion
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Modelling and role‐rehearsal
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Modelling and role‐rehearsal + daily social homework
Number of subjects: 51
Study: 30905721

Group type: EXPERIMENTAL
Intervention: Heavy Resistance Training (HRT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Acute exercise (both groups)
Number of subjects: 25
Study: 29231316

Group type: EXPERIMENTAL
Intervention: Resuscitation acupuncture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pregabalin (75 mg, twice a day)
Number of subjects: 64
Study: 25312997

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention
Number of subjects: 862

Group type: COMPARATOR
Intervention: Control group (AMC)
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Patient factors (college education, private insurance, higher income, older age)
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Clinic type (FQHC vs AMC)
Number of subjects: 862
Study: 23460328

Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (WBVT) for 8 weeks starting from 1 month postoperatively
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional ACL rehabilitation
Number of subjects: 48
Study: 21278620

Group type: EXPERIMENTAL
Intervention: 20-mg IS-5-MN tablet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19904666

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 36
Study: 17026606

Group type: EXPERIMENTAL
Intervention: Proview Eye Pressure Monitor used three times daily for 30 days as an adjunct to the glaucoma regimen
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group with no change in treatment regimen during the study phase
Number of subjects: 32
Study: 14630841

Group type: EXPERIMENTAL
Intervention: Norian SRS cement
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control (cast or external fixator)
Number of subjects: 323
Study: 12387697

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9727991

Group type: COMPARATOR
Intervention: Antibiotics (any)
Number of subjects: 2717

Group type: COMPARATOR
Intervention: More expensive antibiotics
Number of subjects: 2717

Group type: COMPARATOR
Intervention: Other antibiotics
Number of subjects: 2717

Group type: EXPERIMENTAL
Intervention: Amoxycillin and folate inhibitors
Number of subjects: 2717
Study: 8172712

Group type: EXPERIMENTAL
Intervention: Strontium-89 (Metastron®)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hormonal palliation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Half-body irradiation
Number of subjects: 28
Study: 2691885

Group type: COMPARATOR
Intervention: Hypoallergenic formula (semi-elementary formula Alfaré)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Formula adapted to human milk
Number of subjects: 28
Study: 785177

Group type: EXPERIMENTAL
Intervention: 10 mg of sodium-aescinat administered intravenously for 3 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg of aescinat administered for 6 days
Number of subjects: 18
Study: 31850492

Group type: EXPERIMENTAL
Intervention: Priest-led intervention (short message about health during mass)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study: 31014426

Group type: EXPERIMENTAL
Intervention: Interactive group sandplay
Number of subjects: 80

Group type: COMPARATOR
Intervention: Individual sandplay
Number of subjects: 80
Study: 28213610

Group type: EXPERIMENTAL
Intervention: Inulin consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 25456870

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 315

Group type: COMPARATOR
Intervention: Phenprocoumon
Number of subjects: 315
Study: 23520221

Group type: EXPERIMENTAL
Intervention: High-intensity light therapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low-intensity light therapy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 101
Study: 21875638

Group type: EXPERIMENTAL
Intervention: Chinese live attenuated hepatitis A vaccine (H2 strain)
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Domestic inactivated hepatitis A vaccine (Healive(®))
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Imported inactivated hepatitis A vaccine (Havrix(®))
Number of subjects: 841

Group type: COMPARATOR
Intervention: Hepatitis B vaccine (Control group)
Number of subjects: 841
Study: 20141097

Group type: EXPERIMENTAL
Intervention: Various treatment options including pharmacotherapy, implantable cardioverter‐defibrillators, cardiac resynchronization therapy, and heart transplantation.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lifestyle changes such as restricting alcohol consumption, losing weight, exercising, quitting smoking, and eating a low‐sodium diet.
Number of subjects: 0
Study: 16442458

Group type: EXPERIMENTAL
Intervention: Therapeutic education programme using recreational methods and puppets
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Use of puppets in therapeutic education
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Puppets' projective and transactional function
Number of subjects: 14
Study: 15146229

Group type: EXPERIMENTAL
Intervention: Hearing about someone else's cancer
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: New aches and pains
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Joint stiffness
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 244

Group type: COMPARATOR
Intervention: Hearing about someone else's cancer (Caucasian women)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Environmental triggers (Caucasian women)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Information or controversy about breast cancer in media (Caucasian women)
Number of subjects: 244
Study: 11717374

Group type: EXPERIMENTAL
Intervention: Protracted abstinence (12-17 months)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Short abstinence (<6 months)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Neuropsychological tests
Number of subjects: 5
Study: 9812646

Group type: EXPERIMENTAL
Intervention: Composite Danshen Droplet Pills (CDDP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sordi
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 31976576

Group type: EXPERIMENTAL
Intervention: Low-dose oral immunotherapy (OIT) with gradual increase to 53 mg/day for 1 year.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (historical control, avoided wheat).
Number of subjects: 16
Study: 30355825

Group type: EXPERIMENTAL
Intervention: Er:YAG laser for enamel conditioning before pit and fissure sealant application
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine application technique (control)
Number of subjects: 64
Study: 27480813

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy intervention (CBTi) delivered by health-care assistants (HCAs) plus usual care
Number of subjects: 415

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 415
Study: 24161218

Group type: EXPERIMENTAL
Intervention: Feeding dysfunction assessment
Number of subjects: 56

Group type: COMPARATOR
Intervention: Dysfunctional food manipulation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Mealtime aggression
Number of subjects: 56

Group type: COMPARATOR
Intervention: Choking/gagging/vomiting
Number of subjects: 56

Group type: COMPARATOR
Intervention: Resistance to eating
Number of subjects: 56

Group type: COMPARATOR
Intervention: Parental aversion to mealtime
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Weight z-scores
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Height z-scores
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Current gastrostomy tube use
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Single parent household
Number of subjects: 56
Study: 22539845

Group type: EXPERIMENTAL
Intervention: Acute dietary tryptophan depletion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 20003316

Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 2000 IU/day for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 0
Study: 17314918

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 15289384

Group type: EXPERIMENTAL
Intervention: Dobutamine stress MR (DSMR)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adenosine stress MR
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adenosine stress MR perfusion
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adenosine stress MR wall motion
Number of subjects: 79
Study: 11176959

Group type: EXPERIMENTAL
Intervention: Bilateral thalamic deep brain stimulation (DBS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Unilateral thalamic deep brain stimulation (DBS)
Number of subjects: 21
Study: 9503735

Group type: EXPERIMENTAL
Intervention: Patient Held Health Record (PHR)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no PHR)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Post test only group (no PHR)
Number of subjects: 72
Study: 8066868

Group type: EXPERIMENTAL
Intervention: 10 ml carbocaine 1%
Number of subjects: 57

Group type: COMPARATOR
Intervention: 10 ml isotonic NaCl (control)
Number of subjects: 57